Resveratrol, a polyphenol found in grapes and other fruit and vegetables, is a powerful chemopreventive and chemotherapeutic molecule potentially of interest for the treatment of breast cancer. The human breast cancer cell line MCF-7, which is devoid of caspase-3 activity, is refractory to apoptotic cell death after incubation with resveratrol. Here we show that resveratrol arrests cell proliferation, triggers death and decreases the number of colonies of cells that are sensitive to caspase-3-dependent apoptosis (MCF-7 casp-3 ) and also those that are unresponsive to it (MCF-7 vc ). We demonstrate that resveratrol (i) acts via multiple pathways to trigger cell death, (ii) induces caspase-dependent and caspase-independent cell death in MCF-7 casp-3 cells, (iii) induces only caspase-independent cell death in MCF-7 vc cells and (iv) stimulates macroautophagy. Using BECN1 and hVPS34 (human vacuolar protein sorting 34) small interfering RNAs, we demonstrate that resveratrol activates Beclin 1-independent autophagy in both cell lines, whereas cell death via this uncommon form of autophagy occurs only in MCF-7 vc cells. We also show that this variant form of autophagic cell death is blocked by the expression of caspase-3, but not by its enzymatic activity. In conclusion, this study reveals that non-canonical autophagy induced by resveratrol can act as a caspase-independent cell death mechanism in breast cancer cells.
, R Maffei 1 , I Beau 2 , P Codogno* ,2,4 and R Ghidoni* , 1, 4 Resveratrol, a polyphenol found in grapes and other fruit and vegetables, is a powerful chemopreventive and chemotherapeutic molecule potentially of interest for the treatment of breast cancer. The human breast cancer cell line MCF-7, which is devoid of caspase-3 activity, is refractory to apoptotic cell death after incubation with resveratrol. Here we show that resveratrol arrests cell proliferation, triggers death and decreases the number of colonies of cells that are sensitive to caspase-3-dependent apoptosis (MCF-7 casp-3 ) and also those that are unresponsive to it (MCF-7 vc ). We demonstrate that resveratrol (i) acts via multiple pathways to trigger cell death, (ii) induces caspase-dependent and caspase-independent cell death in casp-3 cells, (iii) induces only caspase-independent cell death in MCF-7 vc cells and (iv) stimulates macroautophagy. Using BECN1 and hVPS34 (human vacuolar protein sorting 34) small interfering RNAs, we demonstrate that resveratrol activates Beclin 1-independent autophagy in both cell lines, whereas cell death via this uncommon form of autophagy occurs only in vc cells. We also show that this variant form of autophagic cell death is blocked by the expression of caspase-3, but not by its enzymatic activity. In conclusion, this study reveals that non-canonical autophagy induced by resveratrol can act as a caspase-independent cell death mechanism in breast cancer cells. Macroautophagy (hereafter referred to as autophagy) is an evolutionarily conserved catabolic pathway in which cytoplasmic components are sequestered in vacuoles known as autophagosomes, where they undergo bulk lysosomal degradation. 1, 2 Autophagy is a cytoprotective mechanism that protects cells exposed to situations of metabolic stress, such as nutrient deprivation. 2 Autophagosome formation is dependent on the activity of Atg proteins, evolutionarily conserved from yeast to humans. 3 Of these Atg proteins, the Beclin 1 complex (Beclin 1 is the mammalian ortholog of yeast Atg-6) and two ubiquitin-like conjugation systems, the Atg12 and light chain 3 (LC3) systems (LC3 is the mammalian ortholog of yeast Atg8), act sequentially during the nucleation and expansion of the autophagosomal membrane.
The 'autophagic cell death' is a form of programmed cell death, 4 morphologically distinct from apoptosis and characterized by the accumulation of autophagic vacuoles. Many cancer chemotherapies and radiation are potent inducers of autophagy. 5 Resveratrol (Res), a polyphenol found in grapes, peanuts and other plants, has potent antioxidant and antitumorigenic activities, 6 affects tumor initiation and promotion, and arrests angiogenesis and metastasis. It is also able to stimulate apoptosis, arrest cell cycle and suppress kinase pathways. 7 Res promotes cell death in ovarian carcinoma cells by triggering both autophagy and apoptosis. 8 Additionally, Res inhibits tumor formation in animal models of carcinogenesis. 9, 10 Phase-I human clinical trials of oral Res are currently in progress. 11 Resistance to apoptotic stimuli has been attributed to MCF-7 human breast carcinoma cells. These cells lack caspase-3, due to a 47-base-pair deletion within exon 3 of the caspase-3 gene. 12 Curiously, this cell line is sensitive to Res, although its action cannot be mediated by either caspase-3, which is absent, or by caspase-8, which is unaffected. 13 Nevertheless, the effects of Res on breast cancer MCF-7 cell lines are controversial. Indeed, other studies have demonstrated the occurrence of chromatin condensation and activation of caspase-9 in MCF-7 cells following exposure to Res.
In this study, we investigate the mechanism by which Res induces death in cells that are sensitive or refractory to apoptosis. To this end, we used a cell model involving both caspase-3-competent (MCF-7 casp-3 ) and caspase-3-incompetent (MCF-7 vc ) cells. Our findings show that Res induces both caspase-dependent and caspase-independent cell death, with clearly evident necrotic features in MCF-7 casp-3 cells. In MCF-7 vc , caspase-independent cell death alone occurs in response to Res treatment. Interestingly, Res induces Beclin 1-independent autophagy in both cell populations, as demonstrated by a lack of sensitivity of autophagic markers (LC3-II accumulation, punctate green fluorescent protein (GFP)-LC3 structures, 3-methyladenine (3-MA)-sensitive proteolysis) to BECN1 (Beclin 1) and hVPS34 (human vacuolar protein sorting 34) small interfering RNA (siRNAs). This non-canonical autophagy forms part of the caspaseindependent cell death process in MCF-7 vc cells, but not in MCF-7 casp-3 cells. In conclusion, Res kills cancer cells via several different pathways. Moreover, Res reveals that a novel type of autophagy can be activated in breast cancer cells, which bypasses the activity of tumor suppressor Beclin 1. Finally, the Res-induced autophagic cell death is blocked by the expression of caspase-3, but not by its enzymatic activity.
Results
Res inhibits proliferation and promotes cell death regardless of caspase-3 expression. The biological effects of Res in MCF-7 cells were investigated to determine proliferation index, loss of viability and number of colonies. Res inhibited MCF-7 cell proliferation in a time-and dose-dependent manner, with an efficacy that was unrelated to caspase-3 expression (Figure 1a ). Time-dependent MCF-7 cell death was also promoted by Res, regardless of caspase-3 expression (Figure 1b) . The long-term consequences of Res treatment for cell survival are evident in colony-forming assay where the addition of Res resulted in a 37 and 58% reduction in the number of colonies of MCF-7 casp-3 and MCF-7 vc cells, respectively ( Figure 1c) .
Moreover, Res induced a substantial arrest of the cell cycle in the S phase in both cell populations (Supplementary Figure  S1 ). These data suggest that the effects of Res on cell proliferation and death are unrelated to caspase-3 expression.
Res does not induce caspase-dependent apoptosis when caspase-3 signaling is disrupted. To investigate the ability of Res to induce apoptosis, we performed a Hoechst 33258 (2 0 -(4-hydroxyphenyl)-5-(4-methyl-1-piperazinyl)-2,5 0 -bi-1H-benzimidazole trihydrochloride hydrate bis-benzimide) staining assay. Following Res treatment, MCF-7 casp-3 cells displayed cellular changes (shrinkage, rounding, detachment, membrane blebbing and segregation of cellular structures), whereas MCF-7 vc cells displayed only insignificant hallmarks of DNA damage (Figure 2a, top) . After Res treatment, the percentages of fragmented and condensed nuclei of MCF-7 casp-3 cells at each of the time points were considerably higher than those of MCF-7 vc cells (Figure 2a , bottom).
To find out whether the Res-induced appearance of apoptotic changes was correlated to the activation of caspase-3, we assessed the activity of caspase-3/7 enzyme and investigated the cleavage of poly(ADP-ribose) polymerase (PARP). After exposure to Res, we observed significant activation of caspase-3/7 (three-fold at 48 h and seven-fold at 72 h, versus the corresponding vehicle-treated cells) in casp-3 cells (Figure 2b ). The Res-induced activation of caspase-3 was corroborated by detection of an 85 kDa PARP fragment (Figure 2c ). However, both caspase-3/7 activity and PARP cleavage were completely absent in Res-treated MCF-7 vc cells (Figure 2b and c). These findings suggest that caspase-3 is required for the morphological and biochemical features of apoptosis observed after Res treatment. Res induces typical biomarkers of autophagy regardless of caspase-3 expression. To find out whether Res induced autophagy, we expressed GFP-LC3 in MCF-7 casp-3 and MCF-7 vc cells. During autophagy, LC3 is relocated to the autophagosomal membranes. Thus, the accumulation of GFP-LC3 puncta provides an effective way of detecting autophagosomes. 16 The basal levels of autophagosomes were similar in MCF-7
casp-3 and MCF-7 vc cells (Figure 3a ). After Res treatment, both cell lines showed a significant increase in the number of cells with punctate fluorescence (Figure 3a, left) . Indeed, after exposure to Res, the number of cells with punctate GFP-LC3 staining increased considerably, from 25 to 60% in MCF-7 casp-3 cells, and from 27 to 84% in MCF-7 vc cells (Figure 3a , right). We investigated the conversion of cytosolic LC3-I into LC3-II by western blotting. LC3-II levels correlate with the number of autophagosomes per cell. 16 Res elicited an increase in LC3-II of approximately 2.8-and 1.8-fold in MCF-7
casp-3 and MCF-7 vc cells, respectively (Figure 3b , right). Because the cellular level of LC3-II alone may not accurately reflect autophagic activity, 17 the autophagic flux to the lysosomal compartment was investigated by analyzing LC3-II in cells pretreated with lysosomal cathepsin inhibitors (E64 ((2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester) and pepstatin A (Pep A)) and Res. After Res treatment, we observed an accumulation of LC3-II in the presence of lysosomal inhibitors (Figure 3b) . Moreover, the rate of protein degradation was increased by Res in both cell populations (Figure 4a ). As a positive control, we used C 2 -ceramide (C 2 -Cer), a typical autophagy promoter. 18 In both cell populations, C 2 -Cer increased the percentage of GFP-LC3 punctate cells (Figure 3a -7 casp-3 cells, necrotic cell death was unaffected by adding z-VAD (data not shown).
To find out whether the increase in cell size produced by Res was due to induction of autophagy, we inhibited the gene expression of ATG7, BECN1 or hVPS34 and quantified necrotic cells. We confirmed that stimulation of autophagy was not involved in Res-induced necrosis and cell dilatation (Figure 7c, left) . Accordingly, no change in cell volume was observed in C 2 -Cer-treated cells before or after BECN1 knockdown (Figure 7c These findings support the hypothesis that autophagic vacuoles are formed further upstream and independently of the caspase-dependent death mechanism.
To clarify the caspase-independent cell death, we determined the effect of autophagic impairment on the ability of Res to execute cell death in the presence or absence of z-VAD. The abrogation of ATG7, BECN1 or hVPS34 gene expression did not affect cell death rescue obtained with z-VAD after Res treatment (Figure 8e) . Incubation with the specific inhibitor of caspase-3, z-DEVD, leads to the same biological effects as those produced by z-VAD in MCF-7
casp-3 cells (data not shown). Moreover, knockdown of ATG7 did not modify the percentage of Res-induced cell death (Figure 8e) , nor prevented the appearance of an apoptotic morphology (data not shown). In addition, the Res-induced accumulation of cells in the S phase was not modified after knocking down ATG7 or BECN1 (Supplementary Figure S1) . MCF-7 casp-3 cells, the Res-induced Beclin 1-independent autophagy is unrelated to cell death.
Additionally, to verify that the dissimilarity in autophagy inhibition between Res and C 2 -Cer treatment was not due to differences in timing or to induction of cell death by Res, we tested LC3-II levels after different treatment times. In both cell populations, exposure to Res for a short time (16 h, when cell death is barely detectable) increased the autophagic flux as determined by the analysis of the rate of protein degradation (Figure 4a) and LC3-II level in the presence of lysosomal inhibitors (Supplementary Figure S4) .
To confirm that the role of Beclin 1-independent autophagy in cell death is unrelated to inhibition of caspase-3, we tested Res in caspase-3-positive MDA-MB-231, a highly invasive and metastatic breast cancer cell line. The silencing of ATG7 or BECN1 gene expression (Supplementary Figure S5a) significantly reduced the accumulation of GFP-LC3 puncta (Supplementary Figure S5b) in MDA-MB-231 cells. However, we found that cell death was not totally blocked after z-VAD treatment (Supplementary Figure S5c) similar to inhibition of fragmented and condensed nuclei induced by Res (Supplementary Figure S5d ). By silencing of autophagic gene expression, we observed that Res-induced GFP-LC3 puncta were independent of Beclin 1, but dependent on Atg7 (Supplementary Figure S5b) . However, knockdown of ATG7 did not modify the percentage cell death observed in the presence or absence of z-VAD (Supplementary Figure S5c) .
These data support the conclusion that Res induces both caspase-dependent and caspase-independent cell death in MCF-7 casp-3 cells concomitantly to activating Beclin 1-independent autophagy. The role of Beclin 1-independent autophagy in cell death is therefore not dependent on inhibition of caspase-3.
To investigate whether the expression of caspase-3 governs the role of non-canonical autophagy in Res-induced cell death, we knocked down CASP3 gene in MCF-7 casp-3 cells (Figure 9a ). As shown in Figure 9b , the CASP3 gene silencing protected cells against Res-induced cell death after depletion of ATG7 gene, but not after depletion of BECN1 gene. To confirm the relationship between the expression of caspase-3 and the role of non-canonical autophagy in Resinduced cell death, we transfected MCF-7 vc cells with cDNA encoding the wild-type caspase-3 (casp-3WT) and cDNA encoding a mutant inactive form of caspase-3 (casp-3C163S) (Figure 9d ). We observed that knockdown of ATG7 was no longer able to rescue cells expressing the casp-3C163S mutant from Res-induced cell death (Figure 9c and e) . From these results, we demonstrated that the caspase-3 protein but not its activity is enough to block Beclin 1-independent autophagic cell death in MCF-7 cells.
Discussion
Caspase-3 is the major downstream effector of caspasedependent cell death, and is usually activated by various death signals and cleaves important cellular proteins. 20, 21 Many malignant cells, such as MCF-7 human breast cells, have lost the ability to undergo normal apoptosis, 22 caspase-3 is necessary for apoptosis-related nuclear events 12, 23 but it may not be important for cell death, and a deficit in caspase-3 is not sufficient to block Bax-induced cell death in MCF-7 cells. 24 The purpose of this study is to explore the hypothesis that Res uses autophagy to kill those cells that are unresponsive to drugs that target caspase-dependent apoptotic cell death.
We found that Res exerts a robust antiproliferative effect, induces mortality and reduces the number of colonies in a time-dependent manner in both cell populations. Nevertheless, MCF-7 vc cells are more sensitive to cell death and growth inhibition elicited by Res. These findings are consistent with those showing that disabled apoptosis results in increased radiosensitivity in MCF-7 cells, 25 Bax/Bak À/À double knockout embryonic fibroblasts 26 and the PC3 prostate cell line. 27 Autophagy contributes to cell death in connection with the inhibition of apoptosis, improving tumor cell killing. 28 Moreover, in our study, Res induced a substantial arrest of the cell cycle in the S phase. This ability was most probably due to inhibition of ribonucleotide reductase. 29 Following Res treatment, only the apoptotic-competent MCF-7 cells display the characteristic morphological signs of apoptosis. Thus, when the caspase machinery is active, Res induces cell death by activating caspase-dependent pathways. We assume that genetic constitution and activated signal pathways present in a cancer cell might determine how death is triggered after the chemotherapeutic stimulus. In MCF-7 casp-3 cells, Res triggers both caspase-dependent and caspase-independent cell death, bearing the characteristic hallmarks of necrosis. The ability of Res to elicit necrotic cell death has already been reported in DU145 prostate cells. 30 Res stimulates both apoptosis and autophagy in ovarian carcinoma cells. 8 Here, we found that in MCF-7 cells, Res increases both GFP-LC3 puncta and LC3-II levels via the Atg7 protein.
Nevertheless, our data indicate that the regulation of autophagy activated by Res differs from that of C 2 -Cerinduced autophagy. We found that the autophagic process induced by Res is completely independent of hVps34. Zhu et al. 31 were the first to show the existence of an hVps34/ Beclin 1-independent mechanism of autophagy elicited by neurotoxin 1-methyl-4-phenylpyridinium in pathological situations. Recently, it has been observed that 3-MA did not block autophagy or genesis of vacuoles in miniprotoplasts. 32 Interestingly, in A2780 ovarian cancer cells, which have high levels of Bcl-2/Bcl-x L , which inhibits Beclin 1-dependent autophagy, 33 the effect of Res on autophagy is not invalidated. 8 Overall, this finding supports the existence of a new type of autophagy that is insensitive to PI3K inhibitors.
Nevertheless, further investigations are needed to elucidate the molecular mechanism by which hVps34/Beclin 1-independent autophagy is regulated upstream of the Atg12 and LC3 conjugation systems. However, both canonical (induced by C 2 -Cer) and non-canonical (induced by Res) autophagies are characterized by the inhibition of mTOR signaling. mTOR acts upstream of the Atg1 complex, 34 which suggests that autophagy induced by either Res or C 2 -Cer uses this pathway to trigger the formation of autophagosomes.
When the non-canonical autophagy is invalidated in MCF-7 casp-3 cells, the caspase-independent cell death triggered by Res is neither attenuated nor enhanced. Moreover, in this cell line, the non-canonical autophagy is unconnected to the caspase-activation signal. The accumulation of autophagic vacuoles seems to occur upstream of apoptotic cell death. However, blocking caspase activity in both MCF-7 casp-3 and MDA-MB-231 cells does not uncover a cell death activity for Res-dependent non-canonical autophagy. This contrasts with other settings, where canonical autophagy has been shown to be used as a backup cell death mechanism after caspase inhibition. 35 In this study, we show that the expression of caspase-3, but not its enzymatic activity, is able to modulate the role of noncanonical autophagy in Res-induced cell death after depletion of ATG7. It has been shown that the expression of caspase-3 inhibits growth of MCF-7 cells independently of its catalytic activity, 36 indicating that caspase-3 expression could activate regulatory intracellular pathway(s) other than apoptosis, for example, phosphorylation of AKT. On the basis of these findings, we deduce that this non-canonical form of autophagic cell death is blocked by the expression of caspase-3, but not by its enzymatic activity.
In neurons, Beclin 1-independent autophagy triggered cell death in response to the neurotoxin 1-methyl-4-phenylpyridinium occurs in the absence of caspase activation. 31 A better understanding of the role of non-canonical autophagy calls for an understanding of its molecular control, that is, its regulation and the molecular machinery required to form autophagosomes.
Many targets for Res have been identified in vitro, 7 such as the NAD þ -dependent deacetylase Sir2/SIRT1. 37 Stimulation of the class I PI3K/PKB signaling pathway by growth factors and cytokines has an inhibitory effect on autophagy in many cell types, and in mammalian cells AMP-activated protein kinase was required for autophagy. 38 Moreover, the inhibition of insulin-induced PI3K-PKB-Forkhead box O signaling cascade was due to a direct inhibitory effect of Res on class IA PI3K. It has recently been shown that Res inhibits Akt/PKB and mTOR activation, two downstream kinases of class I PI3K, in ovarian cancer cells. 39 In line with these findings, we now report that Res inhibits the activation of Akt/PKB and mTOR in breast cancer cells. These data suggest that the non-canonical autophagy is triggered by mTOR inhibition in a manner similar to canonical autophagy.
Despite the fact that the specific molecular players involved in non-canonical autophagy remain to be identified, our study shows that breast cancer cells can use the activation of this pathway as a cell death mechanism acting independently of the tumor suppressor Beclin 1. vc and pcDNA3-casp-3-transfected MCF-7 casp-3 cells were the kind gifts of Dr. PT Daniel (Humboldt University, Berlin, Germany). MCF-7 cells were maintained at 371C in 5% CO 2 in RPMI 1640, supplemented with 10% fetal bovine serum and 100 ng/ml each of penicillin and streptomycin. The human breast carcinoma cell line MDA-MB-231 from American Type Culture Collection was maintained at 371C in 5% CO 2 in Dulbecco's modified Eagle's medium, supplemented with 5% fetal bovine serum and 100 ng/ml each of penicillin and streptomycin.
The plasmid expression vector encoding GFP-LC3 (pEGFP-LC3) was kindly provided by T Yoshimori (Research Institute for Microbial Diseases, Osaka University, Osaka, Japan).
siRNAs and treatments. siRNAs for human proteins were synthesized using the following target gene sequences:
0 for hVPS34 and 5 0 -UGACAUCUCGGUCUGCUAC-3 0 for CASP3. The control siRNA was composed of a 19-bp non-target sequence with 3 0 dT overhangs. MCF-7 cells were seeded, and after 24 h transfected in Opti-MEM I Reduced Serum Medium with 50 nmol/l control siRNA, 50 nmol/l BECN1 siRNA, 25 nmol/l ATG7 siRNA, 25 nmol/l hVPS34 siRNA or 25 nmol/l CASP3 siRNA for 4 h using Oligofectamine as recommended by the manufacturer. After 24 h of siRNA treatment, vehicle or Res was added for 48 h. C 2 -Cer was added for 2 h after 72 h of siRNA treatment. At the end of the experiments, cells were collected and the level of protein expression was evaluated by western blotting.
Construction of human caspase-3 mutant. The human caspase-3 cDNA cloned into the pCMV6-XL5 (pCMV-Caspase-3) expression vector was purchased from Origene (Rockville, MD, USA). The pCMV-Caspase-3 plasmid vector was subjected to site-directed mutagenesis using the QuickChange SiteDirected Mutagenesis Kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's instructions.
The Cys163Ser substitution was engineered with two mutagenic primers: primer A, 5 0 -CCCAAACTTTTCATTATTCAGGCCAGCCGTGGTACAGAAC-3 0 , and the reverse primer B, 5 0 -GTTCTGTACCACGGCTGGCCTGAATAATGAAAAGTTTGG G-3 0 . The mutated base is underlined. The construct was verified by sequencing.
Measurement of caspase-3/7 activity. Caspase-3/7 activity was determined using the caspase-3 colorimetric assay kit as described by the manufacturer. Briefly, after lysis, cell extracts were used to determine caspase-3/7 activity by adding the peptide substrate acetyl-Asp-Glu-Val-Asp p-nitroanilide (Ac-DEVD-pNA). In this assay, cleavage of the peptide by the caspase releases pNA, which has a high absorbance at 405 nm. The concentration of pNA released from the substrate was calculated from a calibration curve prepared using defined pNA solutions. The experiments were performed in triplicate.
Necrosis analysis. Necrosis was measured using PI exclusion as previously described. Briefly, 3 Â 10 5 cells/well were seeded in six-well plates and allowed to adhere for 24 h. Cells were treated and at the end of the treatment, cells and medium were collected and cells were stained with PI (5 mg/ml) for 5-10 min. Stained cells were analyzed by flow cytometry (FACSorter, Becton Dickinson). Live gating of the forward and side scatter channels was used to exclude debris and to acquire cell events selectively. Individual fluorescence populations were determined using acquisition and quadrant analysis software (Cell Quest, Becton Dickinson). The experiments were performed in triplicate.
Cell cycle analysis. Cell cycle profile was analyzed by flow cytometric analysis by DNA staining with PI. After treatment, cells were collected, washed with phosphate-buffered saline (PBS) and fixed in 70% ethanol at À201C. Cells were collected by centrifuging and resuspended in 1 ml PBS containing 50 mg/ml PI for 1 h at room temperature. Stained cells were analyzed by flow cytometry on the FACSorter (Becton Dickinson). The percentage of cells in different phases of the cell cycle was determined using the CellQuest software program.
Immunoblotting. Cells were collected by centrifuging (10 min, at 300 Â g), washed with PBS and resuspended in lysis buffer (1% Triton X-100, 5 mM NaCl, 50 mM Tris-HCl pH 7.4, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 1% PIC, 1 mM Na 3 VO 4 , 1 mM NaF) for 1 h on ice. The cell lysate was centrifuged (20 000 Â g for 30 min at 41C) and the supernatant was recovered. Protein concentrations were determined by Coomassie reagent as recommended by the manufacturer. Extracted proteins were first separated in sodium dodecyl sulfatepolyacrylamide gels and then electrotransferred onto nitrocellulose membranes. After blocking for 1 h with fat-free milk, the membranes were incubated with appropriate primary antibodies overnight: anti-Beclin 1 (1 : 10 00), anti-PARP (1 : 500), anti-Atg7 (1 : 4000), anti-hVps34 (1 : 1000), anti-LC3 (1 : 500), anti-P( Thr389 )-p70S6K (1 : 1000), anti-p70S6K (1 : 1000), anti-P( Ser473 )Akt (1 : 1000), anti-Akt/PKB (1 : 1000), anti-caspase-3 (1 : 1000) and anti-b-actin (1 : 1000). Primary antibodies were detected by chemiluminescence using horseradish peroxidase-conjugated secondary antibodies against rabbit immunoglobulin. Fluorographs were quantitatively scanned using the Quantity-One software (Bio-Rad).
Sulforhodamine B proliferation assay. Cells were seeded in 96-well tissue culture plates and allowed to adhere for 24 h before treatment. Cell proliferation was assessed at various time points during treatment with Res by sulforhodamine B monosodium salt assay. Five replicates were used for each treatment. Data are expressed as the proliferation index (fold increase of proliferation versus vehicle-treated cells at time zero).
Cell death. Cell death was determined by Trypan blue exclusion test as described previously. 18 Triplicate samples were used for each treatment. Dead cells were counted by Trypan blue exclusion assay.
Clonogenic assay. Cells were seeded in six-well tissue culture plates and allowed to adhere for 24 h before treatment. Triplicate samples were used for each treatment. The medium containing the treatment was replaced by drug-free medium after the indicated time points. As the colonies became visible (14 days), the cells were fixed with methanol, stained with Giemsa (1 : 10 in H 2 O by volume) and counted.
GFP-LC3 staining. When required, the cells were treated for the times indicated and transfected with 1 mg of GFP-LC3 plasmid for 24 h in Opti-MEM I Reduced Serum Medium by Lipofectamine as recommended by the manufacturer. GFP-LC3 dot staining was visualized using an Axioplan Zeiss microscope and the number of GFP-positive cells with GFP-LC3 dots was determined. More than 100 transfected cells were counted by two investigators. Only cells with at least five dots were scored as positive. Duplicate samples were used for each treatment.
Proteolysis. The rate of long-lived protein degradation was measured as described previously. 40 Briefly, cells were incubated for 24 h at 371C in normal culture medium containing 7400 Bq/ml of [ 14 C]valine. Cells were rinsed three times with PBS (pH 7.4) and then incubated in complete medium supplemented with 10 mM valine. After incubation for 1 h, the medium was replaced by fresh chase medium for an additional 4 h. When required, Res (64 mM, 16 h) or C 2 -Cer (75 mM, 2 h) and 3-MA (10 mM) were added to the chase medium. Cells and radiolabeled proteins from the 4-h chase medium were precipitated in trichloroacetic acid at a final concentration of 10% (v/v) at 4 1C. Radioactivity was determined by liquid scintillation counting. Protein degradation was calculated by dividing the acidsoluble radioactivity recovered from both cells and medium by the radioactivity contained in the precipitated proteins from both cells and medium. Triplicate samples were used for each treatment.
Hoechst staining. Treated cells were fixed with 3.7% paraformaldehyde for 30 min and then stained with Hoechst 33258 (0.5 mg/ml) for 15 min at room temperature. One hundred cells were counted under an Axiovert fluorescence microscope and were scored according to the incidence of apoptotic chromatin changes. Duplicate samples were used for each treatment.
Statistical analysis. Statistical analysis of the differences between the groups was performed using Student's t-test. Significance was established when Po0.05.
